Clinical Trial Update: A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune response and safety of multiple doses of an investigational varicella (chickenpox) vaccine compared with a marketed varicella va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Investigational varicella vaccine (varicella vaccine)
• Marketed varicella vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chickenpox | Phase 2 | Status: COMPLETED | Results posted: 2025-02-28